Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | Onapristone |
| Synonyms | |
| Therapy Description |
Onapristone (ZK299) binds to and inhibits progesterone receptors, potentially resulting in decreased proliferation of progesterone receptor expressing cells (PMID: 32594454). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| Onapristone | ZK299|ZK-98299 | Hormone - Anti-progestins 6 | Onapristone (ZK299) binds to and inhibits progesterone receptors, potentially resulting in decreased proliferation of progesterone receptor expressing cells (PMID: 32594454). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT04142892 | Phase I | Onapristone | Onapristone as Preoperative Treatment for Postmenopausal Women With Hormone Receptor + and HER2- Breast Cancer (ONAWA) | Completed | ESP | 0 |
| NCT03909152 | Phase II | Onapristone Anastrozole + Onapristone | A Study of Onapristone ER Alone Or In Combination With Anastrozole in Gynecologic Cancers That Respond to Progesterone | Completed | USA | 0 |